SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Saeedi Reza) "

Sökning: WFRF:(Saeedi Reza)

  • Resultat 1-10 av 16
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Murray, Christopher J. L., et al. (författare)
  • Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  • 2018
  • Ingår i: The Lancet. - 1474-547X .- 0140-6736. ; 392:10159, s. 1995-2051
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Population estimates underpin demographic and epidemiological research and are used to track progress on numerous international indicators of health and development. To date, internationally available estimates of population and fertility, although useful, have not been produced with transparent and replicable methods and do not use standardised estimates of mortality. We present single-calendar year and single-year of age estimates of fertility and population by sex with standardised and replicable methods. Methods: We estimated population in 195 locations by single year of age and single calendar year from 1950 to 2017 with standardised and replicable methods. We based the estimates on the demographic balancing equation, with inputs of fertility, mortality, population, and migration data. Fertility data came from 7817 location-years of vital registration data, 429 surveys reporting complete birth histories, and 977 surveys and censuses reporting summary birth histories. We estimated age-specific fertility rates (ASFRs; the annual number of livebirths to women of a specified age group per 1000 women in that age group) by use of spatiotemporal Gaussian process regression and used the ASFRs to estimate total fertility rates (TFRs; the average number of children a woman would bear if she survived through the end of the reproductive age span [age 10–54 years] and experienced at each age a particular set of ASFRs observed in the year of interest). Because of sparse data, fertility at ages 10–14 years and 50–54 years was estimated from data on fertility in women aged 15–19 years and 45–49 years, through use of linear regression. Age-specific mortality data came from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 estimates. Data on population came from 1257 censuses and 761 population registry location-years and were adjusted for underenumeration and age misreporting with standard demographic methods. Migration was estimated with the GBD Bayesian demographic balancing model, after incorporating information about refugee migration into the model prior. Final population estimates used the cohort-component method of population projection, with inputs of fertility, mortality, and migration data. Population uncertainty was estimated by use of out-of-sample predictive validity testing. With these data, we estimated the trends in population by age and sex and in fertility by age between 1950 and 2017 in 195 countries and territories. Findings: From 1950 to 2017, TFRs decreased by 49·4% (95% uncertainty interval [UI] 46·4–52·0). The TFR decreased from 4·7 livebirths (4·5–4·9) to 2·4 livebirths (2·2–2·5), and the ASFR of mothers aged 10–19 years decreased from 37 livebirths (34–40) to 22 livebirths (19–24) per 1000 women. Despite reductions in the TFR, the global population has been increasing by an average of 83·8 million people per year since 1985. The global population increased by 197·2% (193·3–200·8) since 1950, from 2·6 billion (2·5–2·6) to 7·6 billion (7·4–7·9) people in 2017; much of this increase was in the proportion of the global population in south Asia and sub-Saharan Africa. The global annual rate of population growth increased between 1950 and 1964, when it peaked at 2·0%; this rate then remained nearly constant until 1970 and then decreased to 1·1% in 2017. Population growth rates in the southeast Asia, east Asia, and Oceania GBD super-region decreased from 2·5% in 1963 to 0·7% in 2017, whereas in sub-Saharan Africa, population growth rates were almost at the highest reported levels ever in 2017, when they were at 2·7%. The global average age increased from 26·6 years in 1950 to 32·1 years in 2017, and the proportion of the population that is of working age (age 15–64 years) increased from 59·9% to 65·3%. At the national level, the TFR decreased in all countries and territories between 1950 and 2017; in 2017, TFRs ranged from a low of 1·0 livebirths (95% UI 0·9–1·2) in Cyprus to a high of 7·1 livebirths (6·8–7·4) in Niger. The TFR under age 25 years (TFU25; number of livebirths expected by age 25 years for a hypothetical woman who survived the age group and was exposed to current ASFRs) in 2017 ranged from 0·08 livebirths (0·07–0·09) in South Korea to 2·4 livebirths (2·2–2·6) in Niger, and the TFR over age 30 years (TFO30; number of livebirths expected for a hypothetical woman ageing from 30 to 54 years who survived the age group and was exposed to current ASFRs) ranged from a low of 0·3 livebirths (0·3–0·4) in Puerto Rico to a high of 3·1 livebirths (3·0–3·2) in Niger. TFO30 was higher than TFU25 in 145 countries and territories in 2017. 33 countries had a negative population growth rate from 2010 to 2017, most of which were located in central, eastern, and western Europe, whereas population growth rates of more than 2·0% were seen in 33 of 46 countries in sub-Saharan Africa. In 2017, less than 65% of the national population was of working age in 12 of 34 high-income countries, and less than 50% of the national population was of working age in Mali, Chad, and Niger. Interpretation: Population trends create demographic dividends and headwinds (ie, economic benefits and detriments) that affect national economies and determine national planning needs. Although TFRs are decreasing, the global population continues to grow as mortality declines, with diverse patterns at the national level and across age groups. To our knowledge, this is the first study to provide transparent and replicable estimates of population and fertility, which can be used to inform decision making and to monitor progress. Funding: Bill & Melinda Gates Foundation.
  •  
2.
  • Stanaway, Jeffrey D., et al. (författare)
  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017
  • 2018
  • Ingår i: The Lancet. - 1474-547X .- 0140-6736. ; 392:10159, s. 1923-1994
  • Tidskriftsartikel (refereegranskat)abstract
    • Background The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk-outcome associations. With each annual GBD study, we update the GBD CRA to incorporate improved methods, new risks and risk-outcome pairs, and new data on risk exposure levels and risk- outcome associations. Methods We used the CRA framework developed for previous iterations of GBD to estimate levels and trends in exposure, attributable deaths, and attributable disability-adjusted life-years (DALYs), by age group, sex, year, and location for 84 behavioural, environmental and occupational, and metabolic risks or groups of risks from 1990 to 2017. This study included 476 risk-outcome pairs that met the GBD study criteria for convincing or probable evidence of causation. We extracted relative risk and exposure estimates from 46 749 randomised controlled trials, cohort studies, household surveys, census data, satellite data, and other sources. We used statistical models to pool data, adjust for bias, and incorporate covariates. Using the counterfactual scenario of theoretical minimum risk exposure level (TMREL), we estimated the portion of deaths and DALYs that could be attributed to a given risk. We explored the relationship between development and risk exposure by modelling the relationship between the Socio-demographic Index (SDI) and risk-weighted exposure prevalence and estimated expected levels of exposure and risk-attributable burden by SDI. Finally, we explored temporal changes in risk-attributable DALYs by decomposing those changes into six main component drivers of change as follows: (1) population growth; (2) changes in population age structures; (3) changes in exposure to environmental and occupational risks; (4) changes in exposure to behavioural risks; (5) changes in exposure to metabolic risks; and (6) changes due to all other factors, approximated as the risk-deleted death and DALY rates, where the risk-deleted rate is the rate that would be observed had we reduced the exposure levels to the TMREL for all risk factors included in GBD 2017.
  •  
3.
  • Abbafati, Cristiana, et al. (författare)
  • 2020
  • Tidskriftsartikel (refereegranskat)
  •  
4.
  • Djalalinia, Shirin, et al. (författare)
  • Prevalence and Years Lived with Disability of 310 Diseases and Injuries in Iran and its Neighboring Countries, 1990-2015 : Findings from Global Burden of Disease Study 2015
  • 2017
  • Ingår i: Archives of Iranian Medicine. - 1029-2977 .- 1735-3947. ; 20:7, s. 392-402
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Due to significant achievements in reducing mortality and increasing life expectancy, the issue of disability from diseases and injuries, and their related interventions, has become one of the most important concerns of health-related research.METHODS: Using data obtained from the GBD 2015 study, the present report provides prevalence and years lived with disability (YLDs) of 310 diseases and injuries by sex and age in Iran and neighboring countries over the period 1990-2015. Age-standardized rates of all causes of YLDs are presented for both males and females in 16 countries for 1990 and 2015. We present the percentage of total YLDs for 21 categories of diseases and injuries, the percentage of YLDs for age groups, as well as the ranking of the most prevalent causes and YLDs from the top 50 diseases and injuries in Iran.RESULTS: In 2015, the burden of 310 diseases and injuries among the Iranian population was responsible for 8,357,878 loss of all-age total years, which is equal to 10.58% of total years lived per year. This differs from the neighboring countries, as it ranges from 9.05% in Turkmenistan to 13.36% in Russia. During the past 25 years, a remarkable decrease was observed in all-cause YLD rates in all 16 countries. Meanwhile, in all countries, the age-standardized rate of all causes of YLDs was higher in females than males.CONCLUSION: Based on our findings, one of the remarkable changes in NCDs observed among the studied age groups was increased rate of YLDs from mental disorders, which was replaced by musculoskeletal disorders in older age groups in 2015.
  •  
5.
  • Feigin, Valery L., et al. (författare)
  • Global, regional, and national burden of stroke and its risk factors, 1990-2019 : a systematic analysis for the Global Burden of Disease Study 2019
  • 2021
  • Ingår i: Lancet Neurology. - : Elsevier. - 1474-4422 .- 1474-4465. ; 20:10, s. 795-820
  • Tidskriftsartikel (refereegranskat)abstract
    • Background Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are important for evidence-based stroke care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national levels. Methods We applied GBD 2019 analytical tools to calculate stroke incidence, prevalence, mortality, disability-adjusted life-years (DALYs), and the population attributable fraction (PAF) of DALYs (with corresponding 95% uncertainty intervals [UIs]) associated with 19 risk factors, for 204 countries and territories from 1990 to 2019. These estimates were provided for ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, and all strokes combined, and stratified by sex, age group, and World Bank country income level. Findings In 2019, there were 12.2 million (95% UI 11.0-13.6) incident cases of stroke, 101 million (93.2-111) prevalent cases of stroke, 143 million (133-153) DALYs due to stroke, and 6.55 million (6.00-7.02) deaths from stroke. Globally, stroke remained the second-leading cause of death (11.6% [10.8-12.2] of total deaths) and the third-leading cause of death and disability combined (5.7% [5.1-6.2] of total DALYs) in 2019. From 1990 to 2019, the absolute number of incident strokes increased by 70.0% (67.0-73.0), prevalent strokes increased by 85.0% (83.0-88.0), deaths from stroke increased by 43.0% (31.0-55.0), and DALYs due to stroke increased by 32.0% (22.0-42.0). During the same period, age-standardised rates of stroke incidence decreased by 17.0% (15.0-18.0), mortality decreased by 36.0% (31.0-42.0), prevalence decreased by 6.0% (5.0-7.0), and DALYs decreased by 36.0% (31.0-42.0). However, among people younger than 70 years, prevalence rates increased by 22.0% (21.0-24.0) and incidence rates increased by 15.0% (12.0-18.0). In 2019, the age-standardised stroke-related mortality rate was 3.6 (3.5-3.8) times higher in the World Bank low-income group than in the World Bank high-income group, and the age-standardised stroke-related DALY rate was 3.7 (3.5-3.9) times higher in the low-income group than the high-income group. Ischaemic stroke constituted 62.4% of all incident strokes in 2019 (7.63 million [6.57-8.96]), while intracerebral haemorrhage constituted 27.9% (3.41 million [2.97-3.91]) and subarachnoid haemorrhage constituted 9.7% (1.18 million [1.01-1.39]). In 2019, the five leading risk factors for stroke were high systolic blood pressure (contributing to 79.6 million [67.7-90.8] DALYs or 55.5% [48.2-62.0] of total stroke DALYs), high body-mass index (34.9 million [22.3-48.6] DALYs or 24.3% [15.7-33.2]), high fasting plasma glucose (28.9 million [19.8-41.5] DALYs or 20.2% [13.8-29.1]), ambient particulate matter pollution (28.7 million [23.4-33.4] DALYs or 20.1% [16.6-23.0]), and smoking (25.3 million [22.6-28.2] DALYs or 17.6% [16.4-19.0]). Interpretation The annual number of strokes and deaths due to stroke increased substantially from 1990 to 2019, despite substantial reductions in age-standardised rates, particularly among people older than 70 years. The highest age-standardised stroke-related mortality and DALY rates were in the World Bank low-income group. The fastest-growing risk factor for stroke between 1990 and 2019 was high body-mass index. Without urgent implementation of effective primary prevention strategies, the stroke burden will probably continue to grow across the world, particularly in low-income countries.
  •  
6.
  • Naghavi, Mohsen, et al. (författare)
  • Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
  • 2015
  • Ingår i: The Lancet. - 1474-547X .- 0140-6736. ; 385:9963, s. 117-171
  • Tidskriftsartikel (refereegranskat)abstract
    • Background Up-to-date evidence on levels and trends for age-sex-specifi c all-cause and cause-specifi c mortality is essential for the formation of global, regional, and national health policies. In the Global Burden of Disease Study 2013 (GBD 2013) we estimated yearly deaths for 188 countries between 1990, and 2013. We used the results to assess whether there is epidemiological convergence across countries. Methods We estimated age-sex-specifi c all-cause mortality using the GBD 2010 methods with some refinements to improve accuracy applied to an updated database of vital registration, survey, and census data. We generally estimated cause of death as in the GBD 2010. Key improvements included the addition of more recent vital registration data for 72 countries, an updated verbal autopsy literature review, two new and detailed data systems for China, and more detail for Mexico, UK, Turkey, and Russia. We improved statistical models for garbage code redistribution. We used six different modelling strategies across the 240 causes; cause of death ensemble modelling (CODEm) was the dominant strategy for causes with sufficient information. Trends for Alzheimer's disease and other dementias were informed by meta-regression of prevalence studies. For pathogen-specifi c causes of diarrhoea and lower respiratory infections we used a counterfactual approach. We computed two measures of convergence (inequality) across countries: the average relative difference across all pairs of countries (Gini coefficient) and the average absolute difference across countries. To summarise broad findings, we used multiple decrement life-tables to decompose probabilities of death from birth to exact age 15 years, from exact age 15 years to exact age 50 years, and from exact age 50 years to exact age 75 years, and life expectancy at birth into major causes. For all quantities reported, we computed 95% uncertainty intervals (UIs). We constrained cause-specific fractions within each age-sex-country-year group to sum to all-cause mortality based on draws from the uncertainty distributions. Findings Global life expectancy for both sexes increased from 65.3 years (UI 65.0-65.6) in 1990, to 71.5 years (UI 71.0-71.9) in 2013, while the number of deaths increased from 47.5 million (UI 46.8-48.2) to 54.9 million (UI 53.6-56.3) over the same interval. Global progress masked variation by age and sex: for children, average absolute diff erences between countries decreased but relative diff erences increased. For women aged 25-39 years and older than 75 years and for men aged 20-49 years and 65 years and older, both absolute and relative diff erences increased. Decomposition of global and regional life expectancy showed the prominent role of reductions in age-standardised death rates for cardiovascular diseases and cancers in high-income regions, and reductions in child deaths from diarrhoea, lower respiratory infections, and neonatal causes in low-income regions. HIV/AIDS reduced life expectancy in southern sub-Saharan Africa. For most communicable causes of death both numbers of deaths and age-standardised death rates fell whereas for most non-communicable causes, demographic shifts have increased numbers of deaths but decreased age-standardised death rates. Global deaths from injury increased by 10.7%, from 4.3 million deaths in 1990 to 4.8 million in 2013; but age-standardised rates declined over the same period by 21%. For some causes of more than 100 000 deaths per year in 2013, age-standardised death rates increased between 1990 and 2013, including HIV/AIDS, pancreatic cancer, atrial fibrillation and flutter, drug use disorders, diabetes, chronic kidney disease, and sickle-cell anaemias. Diarrhoeal diseases, lower respiratory infections, neonatal causes, and malaria are still in the top five causes of death in children younger than 5 years. The most important pathogens are rotavirus for diarrhoea and pneumococcus for lower respiratory infections. Country-specific probabilities of death over three phases of life were substantially varied between and within regions. Interpretation For most countries, the general pattern of reductions in age-sex specifi c mortality has been associated with a progressive shift towards a larger share of the remaining deaths caused by non-communicable disease and injuries. Assessing epidemiological convergence across countries depends on whether an absolute or relative measure of inequality is used. Nevertheless, age-standardised death rates for seven substantial causes are increasing, suggesting the potential for reversals in some countries. Important gaps exist in the empirical data for cause of death estimates for some countries; for example, no national data for India are available for the past decade.
  •  
7.
  • Wang, Haidong, et al. (författare)
  • Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015 : the Global Burden of Disease Study 2015.
  • 2016
  • Ingår i: The lancet. HIV. - : Elsevier. - 2352-3018. ; 3:8, s. e361-e387
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Timely assessment of the burden of HIV/AIDS is essential for policy setting and programme evaluation. In this report from the Global Burden of Disease Study 2015 (GBD 2015), we provide national estimates of levels and trends of HIV/AIDS incidence, prevalence, coverage of antiretroviral therapy (ART), and mortality for 195 countries and territories from 1980 to 2015.METHODS: For countries without high-quality vital registration data, we estimated prevalence and incidence with data from antenatal care clinics and population-based seroprevalence surveys, and with assumptions by age and sex on initial CD4 distribution at infection, CD4 progression rates (probability of progression from higher to lower CD4 cell-count category), on and off antiretroviral therapy (ART) mortality, and mortality from all other causes. Our estimation strategy links the GBD 2015 assessment of all-cause mortality and estimation of incidence and prevalence so that for each draw from the uncertainty distribution all assumptions used in each step are internally consistent. We estimated incidence, prevalence, and death with GBD versions of the Estimation and Projection Package (EPP) and Spectrum software originally developed by the Joint United Nations Programme on HIV/AIDS (UNAIDS). We used an open-source version of EPP and recoded Spectrum for speed, and used updated assumptions from systematic reviews of the literature and GBD demographic data. For countries with high-quality vital registration data, we developed the cohort incidence bias adjustment model to estimate HIV incidence and prevalence largely from the number of deaths caused by HIV recorded in cause-of-death statistics. We corrected these statistics for garbage coding and HIV misclassification.FINDINGS: Global HIV incidence reached its peak in 1997, at 3·3 million new infections (95% uncertainty interval [UI] 3·1-3·4 million). Annual incidence has stayed relatively constant at about 2·6 million per year (range 2·5-2·8 million) since 2005, after a period of fast decline between 1997 and 2005. The number of people living with HIV/AIDS has been steadily increasing and reached 38·8 million (95% UI 37·6-40·4 million) in 2015. At the same time, HIV/AIDS mortality has been declining at a steady pace, from a peak of 1·8 million deaths (95% UI 1·7-1·9 million) in 2005, to 1·2 million deaths (1·1-1·3 million) in 2015. We recorded substantial heterogeneity in the levels and trends of HIV/AIDS across countries. Although many countries have experienced decreases in HIV/AIDS mortality and in annual new infections, other countries have had slowdowns or increases in rates of change in annual new infections.INTERPRETATION: Scale-up of ART and prevention of mother-to-child transmission has been one of the great successes of global health in the past two decades. However, in the past decade, progress in reducing new infections has been slow, development assistance for health devoted to HIV has stagnated, and resources for health in low-income countries have grown slowly. Achievement of the new ambitious goals for HIV enshrined in Sustainable Development Goal 3 and the 90-90-90 UNAIDS targets will be challenging, and will need continued efforts from governments and international agencies in the next 15 years to end AIDS by 2030.
  •  
8.
  • Peyrovan, Sanaz, et al. (författare)
  • Structuring the pharmaceutical parent company organization : A value-based approach, The Case of TPICO
  • 2010
  • Ingår i: IASK International Conference Global Management. - : International Association for the Scientific Knowledge. - 9789898295019 ; , s. 471-476
  • Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
    • Today’s, the parent company has the great role in managing and monitoring subsidiaries and companies and promoting their industrial activities. But, the main problem for pharmaceutical parent companies is the lack of clarity and confusion of   responsibilities between units .The successful parenting needs to create the element of 'fit' between the ways parent operates – parent characteristics – and   its business characteristics. However, the main parent characteristic is parent structure and restructuring is the main challenge in changing and unstable pharmaceutical market. In fact, the parent strategy should determine how value can be added to every organizational structure and parent structure should be proportionate to its dominant value creation strategy. The value drivers are very different in pharmaceutical industry regarding fast changing technology. The aim of this study is to explore an appropriate value-creating structure for the largest pharmaceutical parent company in Iran, TPICO. This study concentrates the sources of value in this special domain and restructuring the parent company by considering the dominant value-creating strategy and pharmaceutical value drivers.
  •  
9.
  • Saeedi, Mohammad Reza (författare)
  • Fostering Dynamic Capabilities of SMEs. The Impact of Inward International Licensing on Absorptive Capacity and Networking Capability : A Multiple Case Study in Pharmaceutical Industry
  • 2014
  • Licentiatavhandling (övrigt vetenskapligt/konstnärligt)abstract
    • Resource limitation and inadequate capabilities are the SME’s major problems. On this basis, alliances as vehicles of inter-firm collaboration provide opportunities for SMEs to obtain complementary capabilities and critical resources to overcome resource limitations. In this respect, examining the extant literature on non-equity strategic alliances shows that very few studies have empirically examined the impact of these alliances, such as inward international licensing (IIL) on SMEs’ dynamic capabilities (e.g. absorptive capacity and networking capability) in developing context. Consequently, to close this research gap, the purpose of this study is to examine and explore the major impacts of inward international licensing (IIL) on dynamic capabilities of SMEs, with focus on absorptive capacity (ACAP) and networking capability (NC) in a developing economy context (Iran).This study is focused on pharmaceutical SMEs involved in international business activities through inward international licensing (IIL). The study is explorative, qualitative and elaborative in nature. The dominant analytical approach in this study was abductive. Given the research type (nature), a multiple-case study was selected as an appropriate research strategy to achieve the research purpose and objectives. All cases were selected purposefully. The data were collected from four pharmaceutical SMEs (licensees) with licenses from European pharmaceutical largescale enterprises (LSEs). The results of the first part of this study reveal that in all cases studied, inward international licensing (IIL) has a strong effect on absorptive capacity (ACAP) and networking capability (NC). In this regard, all absorptive factors (AFs), namely acquisition, assimilation, transformation, and exploitation, have been enhanced by influenced contextual factors (CFs) of ACAP. The SMEs’ management and strategy, human resources, internal knowledge, and inter and intra-firm relationships, as several contextual factors (CF) of ACAP, have been forcefully influenced by inward international licensing (IIL). The second part of the empirical results indicates that the international licensing alliance between SMEs and LSEs helps the development of SMEs’ networking capability as well. This was particularly significant in development of the main components of networking capability, such as relationship initiation capability (RIC) and relationship developing capability (RDC).
  •  
10.
  • Saeedi, Mohammad Reza (författare)
  • Pluripotent Dynamic Capabilities in the Internationalization of Firms : Focus on Learning, Innovating and Networking in SMEs from Sweden
  • 2017
  • Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
    • Internationalization of small and medium-sized enterprises (SMEs) has been a considerable concern for international business (IB) scholars. Particularly, for those economies such as Sweden with small local markets, internationalization of SMEs could be fundamental. The firm-specific advantages (FSAs), including what the firm has and does, are crucial for SMEs to overcome in the face of their numerous different obstacles such as liability of smallness (LOS) and liability of foreignness (LOF).Examining the extant literature on the evolution of IB theories indicates that over time, IB scholars have been reaching to dynamic-based FSAs (what the firm does) as the source of developing and protecting sustainable competitive advantages (SCA) across national borders in a changing business environment. The nature of dynamic-based FSAs could be similar to dynamic capabilities. But, when it comes to determining specific component factors  of dynamic-based  FSAs  (as dynamic  capabilities),  there has been little agreement between IB researchers. In other words, the room of the dynamic capabilities is still dark. In this respect, shedding light into this room, particularly in the area of IB studies, is crucial. In addition, after determining the component factors of the dynamic-based FSAs, it is also critical to know the likely relationships between the identified component factors as well as their impact on the SMEs’ international performance (IP) as an important outcome of the internationalization. This means that there is a potential theoretical gap associated with the conceptualization of the component factors of the dynamic-based FSAs on one hand, and a potential empirical gap on the other. Given both theoretical and empirical research gaps, the purpose of this study is to examine, from a theoretical perspective, the nature of the dynamic-based FSA and its related component factors in the IB context, as well as empirically explore how SMEs’ IP is influenced by the identified component factors of the dynamic-based FSAs.To perform this study, first of all, based on lenses of the resource-based view (RBV) and dynamic capability view (DCV), the literature on organizational capability in the context of the IB studies was systematically reviewed to fill the theoretical gap. Consequently, three component factors of dynamic-based FSAs including networking capability (NC) as a relational-based FSA, innovative capability (IC) as an innovative-based FSA and absorptive capacity (ACAP) as a learning-based FSA were identified, all of which are pluripotent and dynamic in nature. Then, a deductive approach was followed to develop several hypotheses and the associated conceptual model. Furthermore, a survey strategy, collecting data from 330 Swedish internationalized manufacturing SMEs, was applied to accomplish the purpose of the study. Then, the Partial Least Squares Structural Equation Modeling (PLS-SEM) as a quantitative method was used to analyze the collected data.The results of the PLS-SEM analysis show that the SMEs’ international performance (IP) is positively influenced by the three identified component factors, whether directly or indirectly. In this regard, ACAP and NC are the two reliable predictors (directly) of the SMEs’ IP. The results indicate that innovative capability (IC) does not have direct impact on the SMEs’ IP, and that its effect is fully transmitted on IP only by the mediating effect of the networking capability (NC). Further analysis showed that ACAP, as an endogenous latent variable, additionally has a positive indirect association with SMEs’ international performance (IP). Moreover, the results also indicate that innovative capability is directly and positively affected by ACAP (innovating-by-learning effect). It was also empirically revealed that ACAP is a very strong predictor for networking capability, which is labeled as the networking-by-learning effect. Another major finding was that in internationalized SMEs, NC is strongly, directly and positively affected by IC; this effect also is termed as the networking-by-innovating effect. The overall picture resulting from the PLS- SEM analysis indicates that ACAP in internationalized SMEs is a wellspring to develop both innovative capability and networking capability, as well as influence SMEs’ IP. Furthermore, these results suggest that the networking capability is a vital gateway to transmit the effect of the other two component factors on IP and, at the same time, directly influence IP.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 16
Typ av publikation
tidskriftsartikel (10)
konferensbidrag (4)
doktorsavhandling (1)
licentiatavhandling (1)
Typ av innehåll
refereegranskat (11)
övrigt vetenskapligt/konstnärligt (5)
Författare/redaktör
Farzadfar, Farshad (7)
Khader, Yousef Saleh (7)
Murray, Christopher ... (7)
Bensenor, Isabela M. (6)
Dandona, Lalit (6)
Dandona, Rakhi (6)
visa fler...
Jonas, Jost B. (6)
Kumar, G. Anil (6)
Lotufo, Paulo A. (6)
Malekzadeh, Reza (6)
Mendoza, Walter (6)
Mokdad, Ali H. (6)
Naghavi, Mohsen (6)
Sepanlou, Sadaf G. (6)
Yonemoto, Naohiro (6)
Yu, Chuanhua (6)
Moradi-Lakeh, Maziar (6)
Bennett, Derrick A. (6)
Hafezi-Nejad, Nima (6)
Santos, Itamar S. (6)
Singh, Jasvinder A. (6)
Hankey, Graeme J. (5)
Weiderpass, Elisabet ... (5)
Brenner, Hermann (5)
Hay, Simon I. (5)
Dadfar, Hossein (5)
Esteghamati, Alireza (5)
Geleijnse, Johanna M ... (5)
Islami, Farhad (5)
Khang, Young-Ho (5)
Kokubo, Yoshihiro (5)
Lopez, Alan D. (5)
Miller, Ted R. (5)
Tran, Bach Xuan (5)
Vollset, Stein Emil (5)
Vos, Theo (5)
Werdecker, Andrea (5)
Xu, Gelin (5)
Amare, Azmeraw T. (5)
Kim, Daniel (5)
Kinfu, Yohannes (5)
Kosen, Soewarta (5)
Defo, Barthelemy Kua ... (5)
Lim, Stephen S. (5)
Majeed, Azeem (5)
Mueller, Ulrich O. (5)
Pourmalek, Farshad (5)
Sawhney, Monika (5)
Sheikhbahaei, Sara (5)
Tonelli, Marcello (5)
visa färre...
Lärosäte
Linköpings universitet (8)
Karolinska Institutet (4)
Uppsala universitet (3)
Umeå universitet (2)
Lunds universitet (2)
Chalmers tekniska högskola (2)
visa fler...
Göteborgs universitet (1)
Mittuniversitetet (1)
Högskolan Dalarna (1)
visa färre...
Språk
Engelska (16)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (8)
Samhällsvetenskap (7)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy